The Biliary Stents Market is gaining traction as demand for minimally invasive procedures continues to grow. Valued at USD 471.29 million in 2024, the market is projected to expand from USD 497.69 million in 2025 to USD 769.6 million by 2033, at a steady CAGR of 5.6%. Rising cases of biliary diseases, gallstones, and pancreatic cancers are key factors driving adoption worldwide.

Download Sample Report

Key Market Highlights

• Metal stents hold the maximum share by type

• Gallstones dominate applications, influencing market growth

• Hospitals generate the highest revenue share among end-users

Regional Outlook

• North America leads the market, expanding at a CAGR of 5.3%, backed by high cases of bile duct cancer and pancreatitis

• Asia-Pacific is set to grow the fastest at a CAGR of 5.9%, supported by large patient populations and healthcare investments in India, China, and Japan

• Europe remains a strong market due to advanced healthcare infrastructure and favorable regulatory approvals

Key Players

• Boston Scientific

• Cook Group

• ENDO-FLEX GmbH

• Olympus Corporation

• B Braun Melsungen

• CONMED Corporation

• M.I Tech

• Becton, Dickinson & Company

• Medtronic plc

• Cardinal Health

• Merit Medical Systems

Recent Developments

• March 2024 – Boston Scientific received FDA approval for its AGENT™ Drug-Coated Balloon

• March 2024 – BD partnered with GOCC to combat Sepsis in Poland

• January 2024 – Medtronic secured FDA approval for the Percept™ RC neurostimulator with BrainSense™ technology

Market Segmentation

• By Type: Metal, Polymer, Plastic

• By Application: Gallstones, Pancreatic Cancer, Benign Biliary Structures, Biliopancreatic Leakages

• By End-User: Hospitals, Ambulatory Surgical Centers

• By Region: North America, Europe, Asia-Pacific, Middle East & Africa, Latin America

About Us:
Straits Research is a leading global market intelligence and consulting firm, dedicated to delivering actionable insights and in-depth analysis across a wide range of industries. Our mission is to empower organizations, investors, and decision-makers with reliable data, strategic guidance, and forward-looking perspectives to help them thrive in a rapidly evolving business landscape.

Contact Us:
Email: sales@straitsresearch.com
Tel: +1 646 905 0080 (U.S.), +44 203 695 0070 (U.K.)
Website: https://straitsresearch.com/